Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Screening and prevention of gestational hypertension and preeclampsia

Official title: The Project of Gestational Hypertension and Preeclampsia Screening and Prevention

Run by The Third Affiliated Hospital of Guangzhou Medical University · NCT06383858 · Data updated 2026-11-12

This study is testing a new way to identify and manage pregnant women at high risk for preeclampsia to help prevent complications for both mothers and babies.

More Preeclampsia trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment50000 (estimated)
SponsorThe Third Affiliated Hospital of Guangzhou Medical University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedAugust 1, 2023
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedSeptember 19, 2024
Trial IDNCT06383858 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women who have been screened for preeclampsia risk based on clinical guidelines.

Probably not a fit

Patients with severe fetal malformations or those who have been using aspirin regularly prior to joining the study may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate a preeclampsia risk screening scheme based on maternal high-risk factors and placental growth factor (PlGF) detection. It focuses on early prediction and targeted management of high-risk pregnant women to reduce the incidence of preeclampsia and associated complications. By establishing appropriate screening and prevention standards for the Chinese population, the study seeks to significantly lower maternal and fetal mortality rates. The methodology involves real-world assessments and interventions to improve outcomes for pregnant women.

Why it matters

Potential benefit: If successful, this study could lead to a significant reduction in maternal and fetal deaths associated with preeclampsia.

How similar studies have gone: Other studies have shown success with similar screening approaches, indicating potential for effective intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\) Pregnant women who have been screened for pre-eclampsia risk according to the clinical risk factors listed in NICE guidelines (2019);
* 2\) Based on the authoritative guideline of Figo and the consensus of experts in China, pregnant women who routinely use maternal factor +MAP+PLGF±UtA-PI in the first trimester or PLGF or sFlt-1/PLGF in the second and third trimesters to assess the risk of preeclampsia.
* 3\) Meet any of the above conditions, join the group voluntarily, and sign the informed consent form.

Exclusion Criteria:

* 1\) Severe fetal malformation or abnormality (no fetal heartbeat);
* 2\) Those who regularly use aspirin before joining the group;
* 3\) There are obvious other abnormal signs, laboratory tests or other clinical d• iseases, which are judged by the researcher to be not suitable for participating in researchers;
* 4\) Unable to obtain follow-up and delivery information.

Where it's running

  • Fang He
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

  • Principal investigator: Dunjin Chen, Professor — The Third Affiliated Hospital of Guangzhou Medical University
  • Study coordinator: Dunjin Chen, Professor
  • Email: gzdrchen@gzhmu.edu.cn
  • Phone: 18928916722

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.